BBIO (BBIO)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$18.19B
EV / Sales31.37
EV / EBITDA-29.88
EV / Operating Cash Flow-40.98
EV / Free Cash Flow-40.06

Return Metrics (TTM)

Return on Equity (ROE)36.00%
Return on Assets (ROA)-52.95%
Return on Invested Capital (ROIC)-57.94%
Return on Capital Employed (ROCE)-102.90%

Yield Metrics

Earnings Yield-4.65%
Free Cash Flow Yield-2.89%

Balance Sheet Strength

Net Debt / EBITDA-4.11
Current Ratio1.44
Working Capital$362.02M
Tangible Asset Value-$2.30B
Net Current Asset Value-$2.46B

Working Capital Efficiency

Days Sales Outstanding129.16
Days Payables Outstanding294.13
Operating Cycle (Days)462.99
Cash Conversion Cycle168.86

Capital Allocation

CapEx / Revenue1.75%
CapEx / Operating Cash Flow-2.29%
R&D / Revenue84.96%
SG&A / Revenue105.64%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin94.37%
Operating Margin-113.35%
Net Profit Margin-145.26%

Solvency

Debt / Equity-1.31
Quick Ratio2.52
Cash Ratio1.98

Per Share

Revenue / Share$2.55
FCF / Share-$2.27
PE Ratio-20.18